Literature DB >> 16354173

A merging duo in melanoma formation.

Monica Rodolfo1, Marco A Pierotti, Giorgio Parmiani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16354173     DOI： 10.1111/j.0022-202X.2005.23965.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  2 in total

1.  Conserved expression signatures between medaka and human pigment cell tumors.

Authors:  Manfred Schartl; Susanne Kneitz; Brigitta Wilde; Toni Wagner; Christiaan V Henkel; Herman P Spaink; Svenja Meierjohann
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

2.  A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.

Authors:  Tianhong Li; Scott D Christensen; Paul H Frankel; Kim A Margolin; Sanjiv S Agarwala; Thehang Luu; Philip C Mack; Primo N Lara; David R Gandara
Journal:  Invest New Drugs       Date:  2010-10-22       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.